The guidelines
Favilavir is an RNA polymerase inhibitor drug scientists are currently trialling against coronavirus
888-INFO-FDA
Last Updated: November 2, 2023
This is promising for the treatment of COVID-19 by treating the high levels of serum cytokines, inhibiting the cytokine storm inflammatory response
It is the generic version of the brand-name